240 related articles for article (PubMed ID: 17619531)
1. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
Wilputte JY; Goffette P; Zech F; Godoy-Gepert A; Geubel A
Acta Gastroenterol Belg; 2007; 70(1):6-10. PubMed ID: 17619531
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
Campos S; Gomes D; Sofia C
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
[TBL] [Abstract][Full Text] [Related]
4. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
Gordon FD; Anastopoulos HT; Crenshaw W; Gilchrist B; McEniff N; Falchuk KR; LoCicero J; Lewis WD; Jenkins RL; Trey C
Hepatology; 1997 Jun; 25(6):1366-9. PubMed ID: 9185754
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.
Andrade RJ; Martin-Palanca A; Fraile JM; Alcantara R; Carmona C; Medina MC; Muñoz V; Melgarejo F
J Clin Gastroenterol; 1996 Jun; 22(4):305-7. PubMed ID: 8771428
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis.
Jindal A; Mukund A; Kumar G; Sarin SK
Liver Int; 2019 Nov; 39(11):2164-2173. PubMed ID: 31356712
[TBL] [Abstract][Full Text] [Related]
8. [Percutaneous intrahepatic portosystemic shunting as a treatment for refractory hepatic hydrothorax].
Núñez O; García A; Rincón D; Alonso S; Echenagusía A; Bañares R
Gastroenterol Hepatol; 2002 Mar; 25(3):143-7. PubMed ID: 11864535
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rössle M
Eur J Gastroenterol Hepatol; 2001 May; 13(5):529-34. PubMed ID: 11396532
[TBL] [Abstract][Full Text] [Related]
10. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.
Gou X; Jia W; He C; Yuan X; Niu J; Xu J; Han N; Zhu Y; Wang W; Tie J
Eur Radiol; 2023 May; 33(5):3407-3415. PubMed ID: 36576548
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic hydrothorax: report of a series of 77 patients].
Porcel JM; Mas E; Reñé JM; Bielsa S
Med Clin (Barc); 2013 Dec; 141(11):484-6. PubMed ID: 24018252
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites.
Young S; Bermudez J; Zhang L; Rostambeigi N; Golzarian J
Diagn Interv Imaging; 2019 May; 100(5):303-308. PubMed ID: 30522911
[TBL] [Abstract][Full Text] [Related]
13. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt.
Degawa M; Hamasaki K; Yano K; Nakao K; Kato Y; Sakamoto I; Nakata K; Eguchi K
J Gastroenterol; 1999 Feb; 34(1):128-31. PubMed ID: 10204623
[TBL] [Abstract][Full Text] [Related]
14. Refractory Hepatic Hydrothorax in the Absence of Ascites as a First Sign of Cirrhosis.
Aloreidi K; Gedela M; Wabwire G; Mothapothula UM; Jha L
S D Med; 2018 Apr; 71(4):168-170. PubMed ID: 29996034
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax.
Conklin LD; Estrera AL; Weiner MA; Reardon PR; Reardon MJ
Ann Thorac Surg; 2000 Feb; 69(2):609-11. PubMed ID: 10735708
[TBL] [Abstract][Full Text] [Related]
16. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis.
Berry K; Lerrigo R; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):118-23. PubMed ID: 26192147
[TBL] [Abstract][Full Text] [Related]
17. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
[TBL] [Abstract][Full Text] [Related]
18. Further experiments are necessary to determine whether transjugular intrahepatic portosystemic shunt is the definitive treatment for refractory hepatic hydrothorax.
Mitamura K
J Gastroenterol; 1999 Feb; 34(1):154-6. PubMed ID: 10204631
[No Abstract] [Full Text] [Related]
19. Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.
Farsad K; Kolbeck KJ; Keller FS; Barton RE; Kaufman JA
AJR Am J Roentgenol; 2015 Apr; 204(4):868-71. PubMed ID: 25794080
[TBL] [Abstract][Full Text] [Related]
20. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
